Goldman Sachs’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $797K | Sell |
197,654
-68,760
| -26% | -$277K | ﹤0.01% | 3981 |
|
|
2025
Q1 | $727K | Sell |
266,414
-106,618
| -29% | -$291K | ﹤0.01% | 4026 |
|
|
2024
Q4 | $1.59M | Sell |
373,032
-60,024
| -14% | -$255K | ﹤0.01% | 3643 |
|
|
2024
Q3 | $1.27M | Sell |
433,056
-10,776
| -2% | -$31.7K | ﹤0.01% | 3623 |
|
|
2024
Q2 | $1.54M | Buy |
443,832
+274,984
| +163% | +$957K | ﹤0.01% | 3345 |
|
|
2024
Q1 | $481K | Sell |
168,848
-24,546
| -13% | -$70K | ﹤0.01% | 4006 |
|
|
2023
Q4 | $683K | Buy |
193,394
+75,199
| +64% | +$265K | ﹤0.01% | 3795 |
|
|
2023
Q3 | $306K | Sell |
118,195
-1,837,957
| -94% | -$4.76M | ﹤0.01% | 4105 |
|
|
2023
Q2 | $7.71M | Sell |
1,956,152
-637,180
| -25% | -$2.51M | ﹤0.01% | 2242 |
|
|
2023
Q1 | $8.77M | Buy |
2,593,332
+2,502,510
| +2,755% | +$8.46M | ﹤0.01% | 2111 |
|
|
2022
Q4 | $325K | Buy |
90,822
+49,846
| +122% | +$178K | ﹤0.01% | 4310 |
|
|
2022
Q3 | $165K | Buy |
40,976
+28,615
| +231% | +$115K | ﹤0.01% | 4779 |
|
|
2022
Q2 | $55K | Sell |
12,361
-212,063
| -94% | -$944K | ﹤0.01% | 5263 |
|
|
2022
Q1 | $1.91M | Buy |
224,424
+35,047
| +19% | +$297K | ﹤0.01% | 3631 |
|
|
2021
Q4 | $1.67M | Buy |
+189,377
| New | +$1.67M | ﹤0.01% | 3625 |
|
|
2021
Q1 | – | Sell |
-23,529
| Closed | -$261K | – | 5243 |
|
|
2020
Q4 | $261K | Sell |
23,529
-51,471
| -69% | -$571K | ﹤0.01% | 4145 |
|
|
2020
Q3 | $754K | Buy |
+75,000
| New | +$754K | ﹤0.01% | 3464 |
|